Félix de Vicente

Félix de Vicente

Ask VT AI

View News Summary

Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
AI reshapes cities, work, and inequality, with both benefits and concerns around fairness and social harms.
China's industrial profits surge in September, led by high-tech and equipment manufacturing, despite ongoing economic headwinds.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
AI reshapes cities, work, and inequality, with both benefits and concerns around fairness and social harms.
China's industrial profits surge in September, led by high-tech and equipment manufacturing, despite ongoing economic headwinds.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Félix de Vicente